Evestra Snags DoD Grant For Experimental Breast Cancer Drug Research

By David Holley, Xconomy San Antonio—A small Texas biotech that develops women’s health ...

Promising Treatment for Ebola Virus to be Tested at Texas Biomed

Ricardo Carrion, Jr., Ph.D. During the West African Ebola outbreak that began in 2013, an experimental ...


June 8, 2015

When:  Monday, June 8, 2015 from 7:00 AM to 8:00 PM CDT
Where:  Texas Medical Center Accelerator (TMCx), 2450 Holcombe Boulevard, Houston, TX 77021
What:  RESI is an ongoing conference series in Boston, San Francisco, and Houston establishing a global circuit for early stage life science companies, active investors, and service providers to meet, create dialogues, and start relationships – ultimately moving science and technology forward.
RESI@TMCx will bring together fundraising CEOs and early stage investors from across the globe, providing opportunity for dialogue and relationship building, with the goal of eventual capital allocations.
The RESI conference focuses on 10 categories of early stage investors. Through an expansive series of panels and workshops, investors explain their current investment mandates and process for identifying and qualifying candidates.  The RESI Partnering Forum employs a sourcing platform that fundraising CEOs use to identify life science investors who fit their technology sector and stage of development.
To register

Stay informed. Subscribe to BioMed SA news alerts.